Filing Details
- Accession Number:
- 0001179110-20-003307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-09 17:12:47
- Reporting Period:
- 2020-03-05
- Accepted Time:
- 2020-03-09 17:12:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1706857 | Santiago Arroyo | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-05 | 15,000 | $0.00 | 34,576 | No | 4 | A | Direct | |
Common Stock | Disposition | 2020-03-06 | 7,356 | $28.97 | 27,220 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Acquisiton | 2020-03-05 | 15,000 | $0.00 | 15,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,000 | No | 4 | A | Direct |
Footnotes
- Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock.
- Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021.